Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis
Titel:
Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis
Auteur:
Gottlieb, Alice B. Miller, Bruce Lowe, Nicholas Shapiro, William Hudson, Charles Bright, Ross Ling, Mark Magee, Anna McCall, Calvin O. Rist, Toivo Dummer, Wolfgang Walicke, Patricia Bauer, Robert J. White, Mark Garovoy, Marvin